NCT04494867

Brief Summary

The purpose of the proposed pilot study is to determine if core warming improves respiratory physiology of mechanically ventilated patients with COVID-19, allowing earlier weaning from ventilation, and greater overall survival.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 31, 2020

Completed
19 days until next milestone

Study Start

First participant enrolled

August 19, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
1 year until next milestone

Results Posted

Study results publicly available

March 9, 2023

Completed
Last Updated

March 9, 2023

Status Verified

February 1, 2023

Enrollment Period

1.5 years

First QC Date

July 29, 2020

Results QC Date

February 8, 2023

Last Update Submit

February 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • PaO2/FiO2 Ratio

    Determine the change in PaO2/FiO2 ratio at 0, 24, 48, and 72 hours after implementation of core warming of ventilated patients, and compare this change to patients undergoing standard care.

    0, 24, 48, and 72 hours after initiation of core warming

Secondary Outcomes (3)

  • Cycle Threshold at 72-hours

    72 hours after initiation of core warming

  • Ventilator-Free Days

    Initiation of Core Warming Until Patient Weaned Off Mechanical Ventilation

  • 30-Day Mortality

    30 days after initiation of core warming

Study Arms (2)

Core warming

EXPERIMENTAL

Patients receive the Attune Medical Esophageal Heat Transfer Device (EnsoETM) and undergo core warming

Device: Core Warming

Standard of Care

ACTIVE COMPARATOR

Patients receive standard temperature management and treatment

Other: Standard of Care

Interventions

Esophageal heat transfer device will be set to 42°C temperature after initial placement, and maintained at 42°C for the duration of treatment.

Also known as: EnsoETM
Core warming

Standard temperature management and treatment

Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients above the age of 18 years old.
  • Patients with a diagnosis of COVID-19 on mechanical ventilation.
  • Patient maximum baseline temperature (within previous 12 hours) \< 38.3°C.
  • Patients must have a surrogate or legally authorized representative able to understand and critically review the informed consent form.

You may not qualify if:

  • Patients without surrogate or legally authorized representative able to provide informed consent.
  • Patients with contraindication to core warming using an esophageal core warming device.
  • Patients known to be pregnant.
  • Patients with \<40 kg of body mass.
  • Patients with DNR status.
  • Patients with acute stroke, post-cardiac arrest, or multiple sclerosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sharp Memorial Hospital

San Diego, California, 92123, United States

Location

Related Publications (7)

  • Evans EM, Doctor RJ, Gage BF, Hotchkiss RS, Fuller BM, Drewry AM. The Association of Fever and Antipyretic Medication With Outcomes in Mechanically Ventilated Patients: A Cohort Study. Shock. 2019 Aug;52(2):152-159. doi: 10.1097/SHK.0000000000001368.

    PMID: 31058720BACKGROUND
  • Drewry AM, Ablordeppey EA, Murray ET, Dalton CM, Fuller BM, Kollef MH, Hotchkiss RS. Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis. Shock. 2018 Oct;50(4):381-387. doi: 10.1097/SHK.0000000000001083.

    PMID: 29240644BACKGROUND
  • Drewry AM, Ablordeppey EA, Murray ET, Stoll CRT, Izadi SR, Dalton CM, Hardi AC, Fowler SA, Fuller BM, Colditz GA. Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis. Crit Care Med. 2017 May;45(5):806-813. doi: 10.1097/CCM.0000000000002285.

    PMID: 28221185BACKGROUND
  • Drewry AM, Fuller BM, Skrupky LP, Hotchkiss RS. The presence of hypothermia within 24 hours of sepsis diagnosis predicts persistent lymphopenia. Crit Care Med. 2015 Jun;43(6):1165-9. doi: 10.1097/CCM.0000000000000940.

    PMID: 25793436BACKGROUND
  • Drewry AM, Fuller BM, Bailey TC, Hotchkiss RS. Body temperature patterns as a predictor of hospital-acquired sepsis in afebrile adult intensive care unit patients: a case-control study. Crit Care. 2013 Sep 12;17(5):R200. doi: 10.1186/cc12894.

    PMID: 24028682BACKGROUND
  • Drewry AM, Hotchkiss R, Kulstad E. Response to "Body temperature correlates with mortality in COVID-19 patients". Crit Care. 2020 Jul 24;24(1):460. doi: 10.1186/s13054-020-03186-w. No abstract available.

    PMID: 32709253BACKGROUND
  • Bonfanti NP, Mohr NM, Willms DC, Bedimo RJ, Gundert E, Goff KL, Kulstad EB, Drewry AM. Core Warming of Coronavirus Disease 2019 Patients Undergoing Mechanical Ventilation: A Pilot Study. Ther Hypothermia Temp Manag. 2023 Dec;13(4):225-229. doi: 10.1089/ther.2023.0030. Epub 2023 Aug 2.

MeSH Terms

Conditions

COVID-19

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Erik Kulstad, MD
Organization
Attune Medical

Study Officials

  • David Willms, MD

    Sharp HealthCare

    PRINCIPAL INVESTIGATOR
  • Ahmed Salem, MD

    Sharp HealthCare

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Clinical Care Services

Study Record Dates

First Submitted

July 29, 2020

First Posted

July 31, 2020

Study Start

August 19, 2020

Primary Completion

February 28, 2022

Study Completion

February 28, 2022

Last Updated

March 9, 2023

Results First Posted

March 9, 2023

Record last verified: 2023-02

Locations